David versus Goliath: the first round.

Abstract

The IDEAS (Infrapopliteal Drug-Eluting Angioplasty Versus Stenting) trial reported by Siabilis et al. (1), in this issue of JACC: Cardiovascular Interventions, is an independent, single center, self-adjudicated trial of 50 patients randomized to receive paclitaxel drug-coated balloons (DCB) or drug-eluting stents (DES) for treatment of long infrapopliteal lesions. The main result of the study was that DES usage, compared with DCB, significantly reduces vessel.